BCL9 and cancer: detected that knock down of nuclear BCL9 promoted tumorigenesis in murine cancer-associated fibroblasts (CAFs), whereas aberrant inactivation of Wnt/β-catenin due to BCL9 suppression aided T-cell–mediated antitumor immune responses.